A soluble ’anchorminus‘ interleukin 2 receptor suppresses in vitro interleukin 2-mediated immune responses
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 19 (4) , 299-307
- https://doi.org/10.1016/0165-2478(88)90159-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative ActivitiesScience, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.The Journal of Experimental Medicine, 1985
- Recombinant interleukin 2 differentiates alloantigen-primed Lyt-2+ T cells into the activated cytotoxic stateEuropean Journal of Immunology, 1985
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983
- B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor.The Journal of Experimental Medicine, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- T‐Cell Growth FactorImmunological Reviews, 1980
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977